From Nasdaq:

Corbus Pharmaceuticals Holdings Inc. announced plans to offer and sell shares of its common stock in an underwritten registered public offering. The company may also offer pre-funded warrants to certain investors. The proceeds will be used for clinical development of its pipeline and general corporate purposes. The stock closed Tuesday’s trading at $25.16, up 35.12% and gained an additional 13.28% in after-hours trading.



Read more: Corbus Pharma Announces Proposed Public Offering; Stock Surges